246 related articles for article (PubMed ID: 20483958)
1. Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin.
Li D; Bareja A; Judge L; Yue Y; Lai Y; Fairclough R; Davies KE; Chamberlain JS; Duan D
J Cell Sci; 2010 Jun; 123(Pt 12):2008-13. PubMed ID: 20483958
[TBL] [Abstract][Full Text] [Related]
2. Dystrophin R16/17 protein therapy restores sarcolemmal nNOS in trans and improves muscle perfusion and function.
Zhao J; Yang HT; Wasala L; Zhang K; Yue Y; Duan D; Lai Y
Mol Med; 2019 Jul; 25(1):31. PubMed ID: 31266455
[TBL] [Abstract][Full Text] [Related]
3. Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy.
Lai Y; Thomas GD; Yue Y; Yang HT; Li D; Long C; Judge L; Bostick B; Chamberlain JS; Terjung RL; Duan D
J Clin Invest; 2009 Mar; 119(3):624-35. PubMed ID: 19229108
[TBL] [Abstract][Full Text] [Related]
4. Neuronal nitric oxide synthase localizes to utrophin expressing intercalated discs and stabilizes their structural integrity.
Gonzalez JP; Crassous PA; Schneider JS; Beuve A; Fraidenraich D
Neuromuscul Disord; 2015 Dec; 25(12):964-76. PubMed ID: 26483274
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide signalling pathway in Duchenne muscular dystrophy mice: up-regulation of L-arginine transporters.
Ramachandran J; Schneider JS; Crassous PA; Zheng R; Gonzalez JP; Xie LH; Beuve A; Fraidenraich D; Peluffo RD
Biochem J; 2013 Jan; 449(1):133-42. PubMed ID: 23009292
[TBL] [Abstract][Full Text] [Related]
6. α2 and α3 helices of dystrophin R16 and R17 frame a microdomain in the α1 helix of dystrophin R17 for neuronal NOS binding.
Lai Y; Zhao J; Yue Y; Duan D
Proc Natl Acad Sci U S A; 2013 Jan; 110(2):525-30. PubMed ID: 23185009
[TBL] [Abstract][Full Text] [Related]
7. Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy.
Zhang Y; Yue Y; Li L; Hakim CH; Zhang K; Thomas GD; Duan D
Hum Mol Genet; 2013 Sep; 22(18):3720-9. PubMed ID: 23681067
[TBL] [Abstract][Full Text] [Related]
8. Loss of sarcospan exacerbates pathology in mdx mice, but does not affect utrophin amelioration of disease.
Gibbs EM; McCourt JL; Shin KM; Hammond KG; Marshall JL; Crosbie RH
Hum Mol Genet; 2021 Apr; 30(3-4):149-159. PubMed ID: 33432327
[TBL] [Abstract][Full Text] [Related]
9. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
Guo Y; Petrof BJ; Hussain SN
Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
[TBL] [Abstract][Full Text] [Related]
10. Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle.
Wells KE; Torelli S; Lu Q; Brown SC; Partridge T; Muntoni F; Wells DJ
Neuromuscul Disord; 2003 Jan; 13(1):21-31. PubMed ID: 12467729
[TBL] [Abstract][Full Text] [Related]
11. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
[TBL] [Abstract][Full Text] [Related]
12. The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy.
Guiraud S; Edwards B; Babbs A; Squire SE; Berg A; Moir L; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jul; 28(13):2189-2200. PubMed ID: 30990876
[TBL] [Abstract][Full Text] [Related]
13. Neuronal nitric oxide synthase-rescue of dystrophin/utrophin double knockout mice does not require nNOS localization to the cell membrane.
Wehling-Henricks M; Tidball JG
PLoS One; 2011; 6(10):e25071. PubMed ID: 22003386
[TBL] [Abstract][Full Text] [Related]
14. Differential targeting of nNOS and AQP4 to dystrophin-deficient sarcolemma by membrane-directed alpha-dystrobrevin.
Adams ME; Tesch Y; Percival JM; Albrecht DE; Conhaim JI; Anderson K; Froehner SC
J Cell Sci; 2008 Jan; 121(Pt 1):48-54. PubMed ID: 18057022
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.
Janghra N; Morgan JE; Sewry CA; Wilson FX; Davies KE; Muntoni F; Tinsley J
PLoS One; 2016; 11(3):e0150818. PubMed ID: 26974331
[TBL] [Abstract][Full Text] [Related]
16. Dystrophin R16/17-syntrophin PDZ fusion protein restores sarcolemmal nNOSμ.
Patel A; Zhao J; Yue Y; Zhang K; Duan D; Lai Y
Skelet Muscle; 2018 Nov; 8(1):36. PubMed ID: 30466494
[TBL] [Abstract][Full Text] [Related]
17. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions.
Torelli S; Brown SC; Jimenez-Mallebrera C; Feng L; Muntoni F; Sewry CA
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):540-5. PubMed ID: 15488030
[TBL] [Abstract][Full Text] [Related]
18. Sarcolemmal targeting of nNOSμ improves contractile function of mdx muscle.
Rebolledo DL; Kim MJ; Whitehead NP; Adams ME; Froehner SC
Hum Mol Genet; 2016 Jan; 25(1):158-66. PubMed ID: 26604149
[TBL] [Abstract][Full Text] [Related]
19. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.
Parvatiyar MS; Brownstein AJ; Kanashiro-Takeuchi RM; Collado JR; Dieseldorff Jones KM; Gopal J; Hammond KG; Marshall JL; Ferrel A; Beedle AM; Chamberlain JS; Renato Pinto J; Crosbie RH
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31039133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
